Geneos Wealth Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Geneos Wealth Management's ABMD Position: Q4 2022 in Review
Geneos Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 100 shares — an estimated $24K sold.
Geneos Wealth Management first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $269K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Geneos Wealth Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Geneos Wealth Management sold 100 Abiomed Inc shares in Q4 2022, an estimated $24K.
- Geneos Wealth Management first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
- Geneos Wealth Management's Abiomed Inc position peaked at $269K in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Geneos Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.